Argenx Se (ARGX) Intangibles (2015 - 2025)
Argenx Se (ARGX) posted Intangibles of $272.1 million for Q4 2025, down 99.88% on a QoQ basis from $219.0 billion in Q2 2025, and up 49.96% year-over-year from $181.4 million in Q4 2024.
Argenx Se (ARGX) Intangibles (2015 - 2025) Analysis & Trends
Argenx Se's Intangibles history runs 11 years deep, the most recent figure standing at $272.1 million for Q4 2025.
- Quarterly Intangibles rose 49.96% year-over-year to $272.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $272.1 million (up 49.96% YoY) and the FY2025 annual result came in at $272.1 million, up 49.96% from the prior year.
- Intangibles was $272.1 million for Q4 2025 at Argenx Se, down from $219.0 billion in the prior quarter.
- Across five years, Intangibles topped out at $219.0 billion in Q2 2025 and bottomed at $125.2 million in Q4 2023.
- A 5-year average of $24.5 billion and a median of $175.2 million in 2021 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2024 — Intangibles decreased 25.33% — and 2025, when it jumped 154354.98%.
- Argenx Se's Intangibles stood at $171.7 million in 2021, then fell by 0.23% to $171.3 million in 2022, then retreated by 26.89% to $125.2 million in 2023, then jumped by 44.89% to $181.4 million in 2024, then soared by 49.96% to $272.1 million in 2025.
- Business Quant data shows ARGX's Intangibles at $272.1 million in Q4 2025, $219.0 billion in Q2 2025, and $181.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 11,640.44 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 61.68 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 55.80 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 272.10 Mn |
| Jun 30, 2025 | 218.98 Bn |
| Dec 31, 2024 | 181.45 Mn |
| Jun 30, 2024 | 141.77 Mn |
| Dec 31, 2023 | 125.23 Mn |
| Jun 30, 2023 | 189.86 Mn |
| Jun 30, 2022 | 171.29 Mn |
| Dec 31, 2021 | 171.68 Mn |
| Jun 30, 2021 | 175.17 Mn |
| Dec 31, 2020 | 162.64 Mn |
| Jun 30, 2020 | 45.10 Mn |
| Dec 31, 2019 | 44.45 Mn |
| Jun 30, 2019 | 39.86 Mn |
| Dec 31, 2018 | 63,918.20 |
| Jun 30, 2018 | 9,547.56 |
| Dec 31, 2017 | 116,565.82 |
| Jun 30, 2017 | 13,194.59 |
| Dec 31, 2016 | 18,355.31 |
| Dec 31, 2015 | 7,672.82 |